Articles from Worldwide Biotech (September 1, 2007)

1-4 out of 4 article(s)

Title	Type	Words
BIOLINERX STARTS PHASE II TRIAL OF BL-1020 FOR SCHIZOPHRENIA.		661
BIOLINERX/UNIVERSITY OF ILLINOIS TO DEVELOP APOPTOSIS AGENT.		665
STARPHARMA REPORTS POSITIVE RESULTS WITH VIVAGEL.	Financial report	588
TIKVAH LICENSES ACADEMIA SINICA NEURODEGENERATIVE PATENTS.		951

Publications by Name	Publications by Date	Authors	Literature
A-D E-O P-T U-Z	17 74 75 78 80 82 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09 10	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z